论文部分内容阅读
大西北是我国五大牧区之一,无垠的 草地上牛羊成群,有着丰富的动物脏器资源,对开发生产生化药品有着得天独厚的条件。兰州大得利生物化学制药(厂)有限公司据此有利条件应运而生。 公司于1993年2月成立,由香港宏惠公司杨国良先生独资经营,投资420万港币,分期投入建成了粗品原料加工、符合GMP标准的原料精制和符合GMP标准的分包装三条生产线,开发生产柳肽酶、绒促性素、尿促性素、凝血酶等生化药品。抑肽酶
The Northwest is one of the five largest pastoral areas in China. The innocent cattle and sheep herds on the grassland have abundant animal organ resources and are endowed with unique conditions for producing chemical products. Lanzhou Dayeli Biochemical Pharmaceutical (Plant) Co., Ltd. came into being according to this favorable condition. The company was established in February 1993. It is wholly-owned by Mr. Yang Guoliang, Hong Kong Honghui company. It invested 4.2 million Hong Kong dollars to complete the three production lines of crude raw material processing, raw material refinement in line with GMP standards, and subcontracting in line with GMP standards. Biopharmaceuticals such as lypeptin, chorionic gonadotropins, urinary stimulants, and thrombin. Aprotinin